Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) Short Interest Update

Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) was the target of a significant increase in short interest during the month of August. As of August 31st, there was short interest totalling 1,834,800 shares, an increase of 10.5% from the August 15th total of 1,661,100 shares. Based on an average daily trading volume, of 5,263,800 shares, the short-interest ratio is currently 0.3 days.

Elite Pharmaceuticals Stock Performance

ELTP stock traded down $0.01 during midday trading on Wednesday, reaching $0.38. The stock had a trading volume of 1,393,660 shares, compared to its average volume of 1,253,772. The firm has a fifty day simple moving average of $0.23 and a two-hundred day simple moving average of $0.18. Elite Pharmaceuticals has a 52-week low of $0.08 and a 52-week high of $0.42. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.09 and a current ratio of 3.08. The stock has a market cap of $408.64 million, a PE ratio of 38.25 and a beta of 0.18.

Elite Pharmaceuticals Company Profile

Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.